What's in Derm Research, PLLC's pipeline?

Derm Research, PLLC has 8 drugs in our index: 8 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Derm Research, PLLC's portfolio?

Top competitors by shared drug class: Galderma R&D, American University of Beirut Medical Center, China International Neuroscience Institution, Eye Therapies, LLC, GWT-TUD GmbH.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/derm-research-pllc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Derm Research, PLLC — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Derm Research, PLLC pipeline: 8 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

8 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
ONEXTON Topical Gel	ONEXTON Topical Gel	marketed
Adapalene/Benzoyl Peroxide Gel 0.3-2.5%	Adapalene/Benzoyl Peroxide Gel 0.3-2.5%	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)	Dermatology
Eucerin Lotion	Eucerin Lotion	marketed			Dermatology
Aczone 5% gel	Aczone 5% gel	marketed	Sulfone antimicrobial agent	Bacterial dihydropteroate synthase; anti-inflammatory mechanisms	Dermatology
Brimonidine 0.33%	Brimonidine 0.33%	marketed	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor	Dermatology
Hydrogel vehicle	Hydrogel vehicle	marketed			Dermatology
Dapsone 7.5 % gel	Dapsone 7.5 % gel	marketed	Sulfone antibiotic with anti-inflammatory properties	Dihydropteroate synthase; neutrophil function and inflammatory mediators	Dermatology
Calcipotriene/betamethasone	Calcipotriene/betamethasone	marketed	Vitamin D analog / Corticosteroid combination	Vitamin D receptor (VDR) / Glucocorticoid receptor (GR)	Dermatology

Therapeutic area mix

Dermatology · 7

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Galderma R&D · 2 shared drug classes
American University of Beirut Medical Center · 1 shared drug class
China International Neuroscience Institution · 1 shared drug class
Eye Therapies, LLC · 1 shared drug class
GWT-TUD GmbH · 1 shared drug class
Galderma Brasil Ltda. · 1 shared drug class
Almirall, S.A. · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Derm Research, PLLC:

Cite this brief

Drug Landscape (2026). Derm Research, PLLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/derm-research-pllc. Accessed 2026-06-10.